The case involves a California woman who died from mesothelioma, a rare cancer. Her family claimed Johnson and Johnson’s talc ...

Johnson & Johnson will spin off its $9.2B orthopedics business into a new company, DePuy Synthes, to focus on faster-growing medtech areas.

Johnson & Johnson (J&J) is confronting its first major legal challenge in the United Kingdom, with more than 3,000 claimants ...

Jonhson and Johnson announced its intention to separate its orthopaedics business to enhance both the strategic and operational focus of each company, while also improving value for stakeholders. 1 ...

The mineral is linked to mesothelioma, lung, laryngeal and ovarian cancers and is banned in over 60 countries. In the US, ...

The planned separation is the latest move by J&J to slim down in recent years and focus on faster-growing businesses.